Ondansetron Hydrochloride Injection Market

Itis indicated for the prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.

Ondansetron Hydrochloride Injection Market contains market size and forecasts of Ondansetron Hydrochloride Injection in global, including the following market information:

Global Ondansetron Hydrochloride Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Ondansetron Hydrochloride Injection Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Ondansetron Hydrochloride Injection companies in 2021 (%)

The global Ondansetron Hydrochloride Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

2ml/vial Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Ondansetron Hydrochloride Injection include Athenex, AuroMedics, Fresenius Kabi, Pfizer, Apotex, Heritage, Mylan, Sagent and Novartis. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Ondansetron Hydrochloride Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Ondansetron Hydrochloride Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Ondansetron Hydrochloride Injection Market Segment Percentages, by Type, 2021 (%)

• 2ml/vial
• 20ml/vial

Global Ondansetron Hydrochloride Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Ondansetron Hydrochloride Injection Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Special Clinic
• Recovery Center

Global Ondansetron Hydrochloride Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Ondansetron Hydrochloride Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Ondansetron Hydrochloride Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Ondansetron Hydrochloride Injection revenues share in global market, 2021 (%)
• Key companies Ondansetron Hydrochloride Injection sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Ondansetron Hydrochloride Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Athenex
• AuroMedics
• Fresenius Kabi
• Pfizer
• Apotex
• Heritage
• Mylan
• Sagent
• Novartis